MG132 dramatically reduces SAA expression in chicken hepatocellular carcinoma cells at the transcript level independent of its endogenous promoter
Molecular Biology Reports · 2024
DOI: 10.1007/s11033-024-09726-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Nora-Fabienne Paul und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Sciences, Division of Functional Breeding, Georg-August-Universität Göttingen, Burckhardtweg 2, 37077, Göttingen, Germany. Hauptthemen laut MEDLINE: Leupeptins, Chickens, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Georg-August-Universität Göttingen.
Abstract (Originalsprache)
Background
MG132, a proteasome inhibitor, is widely used to inhibit nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activity by proteasome-mediated degradation of IκB. It has been marketed as a specific, reversible, cell-permeable and low-cost inhibitor. However, adverse effects of the compound have been reported in the literature. We recently discovered and characterised a point mutation in the acute phase protein serum amyloid A (SAA) in chickens, by overexpressing the protein in chicken hepatocellular carcinoma (LMH) cells. This serine to arginine exchange at amino acid position 90 (SAA.R90S) leads to intra- and extracellular accumulation of SAA, which is surprisingly counteracted by MG132 treatment, independent of SAA ’s intrinsic promoter. Methods and Results To test, whether low proteasomal degradation of SAA.R90S is responsible for the observed intra- and extracellular SAA accumulation, we intended to inhibit the proteasome in SAA wild type (SAA.WT) overexpressing cells with MG132. However, we observed an unexpected drastic decrease in SAA protein expression at the transcript level. NF-κB gene expression was unchanged by MG132 at the measured time point.
Conclusions
The observed results demonstrate that MG132 inhibits SAA expression at the transcript level, independent of its endogenous promoter. Further, the data might indicate that NF-κB is not involved in the observed MG132-induced inhibition of SAA expression. We, consequently, question in this brief report whether MG132 should truly be categorised as a specific ubiquitin proteasome inhibitor and recommend the usage of alternative compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Animal Sciences, Division of Functional Breeding, Georg-August-Universität Göttingen, Burckhardtweg 2, 37077, Göttingen, Germany.
- Center for Integrated Breeding Research, Georg-August-University, Albrecht-Thaer-Weg 3, 37075, Göttingen, Germany.
- Department of Animal Sciences, Division of Functional Breeding, Georg-August-Universität Göttingen, Burckhardtweg 2, 37077, Göttingen, Germany. clemens.falker-gieske@uni-goettingen.de.
- Center for Integrated Breeding Research, Georg-August-University, Albrecht-Thaer-Weg 3, 37075, Göttingen, Germany. clemens.falker-gieske@uni-goettingen.de.
Förderung
- Georg-August-Universität Göttingen
Zitieren
APA
Paul, N. F., Gustmann, K., Tetens, J., & Falker-Gieske, C. (2024). MG132 dramatically reduces SAA expression in chicken hepatocellular carcinoma cells at the transcript level independent of its endogenous promoter. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09726-9
Vancouver
Paul NF, Gustmann K, Tetens J, Falker-Gieske C. MG132 dramatically reduces SAA expression in chicken hepatocellular carcinoma cells at the transcript level independent of its endogenous promoter. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09726-9
BibTeX
@article{Paul2024,
author = {Paul, Nora-Fabienne and Gustmann, Karolin and Tetens, Jens and Falker-Gieske, Clemens},
title = {MG132 dramatically reduces SAA expression in chicken hepatocellular carcinoma cells at the transcript level independent of its endogenous promoter},
journal = {Molecular Biology Reports},
year = {2024},
doi = {10.1007/s11033-024-09726-9}
}
EUVIMED